No. |
Chromosome Location |
Chromatin state |
Cell line |
Tissue |
1 |
chr1:151819200-151847600 |
Weak transcription |
Thymus |
Thymus
|
2 |
chr1:151821600-151845600 |
Weak transcription |
Primary T regulatory cells fromperipheralblood |
blood
|
3 |
chr1:151826400-151846200 |
Weak transcription |
Primary T helper 17 cells PMA-I stimulated |
--
|
4 |
chr1:151827600-151839800 |
Weak transcription |
Hela-S3 |
cervix
|
5 |
chr1:151828200-151835400 |
Enhancers |
Primary monocytes fromperipheralblood |
blood
|
6 |
chr1:151828800-151837000 |
Weak transcription |
Right Ventricle |
heart
|
7 |
chr1:151829000-151845200 |
Weak transcription |
Primary hematopoietic stem cells G-CSF-mobilized Male |
--
|
8 |
chr1:151829400-151834200 |
Enhancers |
Breast Myoepithelial Primary Cells |
Breast
|
9 |
chr1:151830000-151833400 |
Enhancers |
HMEC |
breast
|
10 |
chr1:151830000-151833600 |
Enhancers |
NHEK |
skin
|
11 |
chr1:151830000-151833800 |
Enhancers |
Foreskin Keratinocyte Primary Cells skin03 |
Skin
|
12 |
chr1:151830600-151834400 |
Enhancers |
H1 BMP4 Derived Trophoblast Cultured Cells |
ES cell derived
|
13 |
chr1:151831000-151834000 |
Enhancers |
Esophagus |
oesophagus
|
14 |
chr1:151831000-151881400 |
Weak transcription |
Ovary |
ovary
|
15 |
chr1:151831200-151835000 |
Enhancers |
Placenta |
Placenta
|
16 |
chr1:151831600-151834200 |
Bivalent Enhancer |
ES-UCSF4 Cell Line |
embryonic stem cell
|
17 |
chr1:151831800-151834000 |
Weak transcription |
Monocytes-CD14+_RO01746 |
blood
|
18 |
chr1:151832000-151833000 |
Enhancers |
Primary hematopoietic stem cells short term culture |
blood
|
19 |
chr1:151832000-151833400 |
Enhancers |
Primary B cells from peripheral blood |
blood
|
20 |
chr1:151832000-151859600 |
Weak transcription |
hESC Derived CD56+ Mesoderm Cultured Cells |
ES cell derived
|
21 |
chr1:151832200-151833400 |
Enhancers |
GM12878-XiMat |
blood
|
22 |
chr1:151832200-151834000 |
Bivalent Enhancer |
H1 Cell Line |
embryonic stem cell
|
23 |
chr1:151832200-151834400 |
Bivalent Enhancer |
ES-I3 Cell Line |
embryonic stem cell
|
24 |
chr1:151832400-151833800 |
Bivalent Enhancer |
Fetal Muscle Trunk |
muscle
|
25 |
chr1:151832400-151834400 |
Bivalent Enhancer |
HUES6 Cell Line |
embryonic stem cell
|
26 |
chr1:151832600-151833200 |
Bivalent Enhancer |
ES-WA7 Cell Line |
embryonic stem cell
|
27 |
chr1:151832600-151833400 |
Weak transcription |
Fetal Thymus |
thymus
|
28 |
chr1:151832600-151834000 |
Bivalent Enhancer |
HUES64 Cell Line |
embryonic stem cell
|
29 |
chr1:151832600-151834200 |
Bivalent Enhancer |
iPS DF 6.9 Cell Line |
embryonic stem cell
|
30 |
chr1:151832600-151834400 |
Bivalent Enhancer |
HUES48 Cell Line |
embryonic stem cell
|
31 |
chr1:151832800-151833000 |
Weak transcription |
hESC Derived CD56+ Ectoderm Cultured Cells |
ES cell derived
|
32 |
chr1:151832800-151833000 |
Bivalent Enhancer |
iPS-15b Cell Line |
embryonic stem cell
|
33 |
chr1:151832800-151833200 |
Bivalent Enhancer |
iPS-18 Cell Line |
embryonic stem cell
|
34 |
chr1:151832800-151833200 |
Flanking Bivalent TSS/Enh |
iPS-20b Cell Line |
embryonic stem cell
|
35 |
chr1:151832800-151833200 |
Weak transcription |
Foreskin Keratinocyte Primary Cells skin02 |
Skin
|
36 |
chr1:151832800-151833400 |
Bivalent Enhancer |
Fetal Adrenal Gland |
Adrenal Gland
|
37 |
chr1:151832800-151834200 |
Bivalent Enhancer |
iPS DF 19.11 Cell Line |
embryonic stem cell
|
38 |
chr1:151832800-151840000 |
Weak transcription |
Breast variant Human Mammary Epithelial Cells (vHMEC) |
Breast
|
39 |
chr1:151832800-151846000 |
Weak transcription |
Spleen |
Spleen
|